Emerging role of long acting muscarinic antagonists for asthma - Lipworth - 2014 - British Journal of Clinical Pharmacology - Wiley Online Library
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Rspiratory pptx - د. حسين محمد جمعة - Muhadharaty
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
Just Breathe: Clinical Updates in the Treatment of Asthma and COPD - ppt download
Navigating New Treatment Options for COPD | Consultant360
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD) - Horita, N - 2017 | Cochrane Library
Learn More Breathe Better - A long-acting muscarinic antagonist (LAMA) is a medicine that may help control asthma long-term. Download this fact sheet to learn more about LAMAs and how they're used:
Soft-mist LAMA/LABA combination inhaler launched for COPD | MIMS online
New developments in inhaled therapy | Practice Nursing
Revefenacin for COPD Patients With Suboptimal PIFR | Journal of The COPD Foundation
Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression - Yuji Oba, Nazir A. Lone, 2015
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Does my patient still need A long-acting inhaler? — PDC Rx
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD | Scientific Reports